Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece

Cosmos Health has partnered with Libytec Pharmaceutical to commercialize DIABIT-IS X (sitagliptin), a generic diabetes medication, in Greece. Under a five-year agreement, Cosmos will supply the drug while Libytec handles distribution and promotion. As a prescription medicine covered by Greece's national health insurance system, DIABIT-IS X is positioned to reach a broad patient population and contribute meaningfully to revenue and cash flow.